Pool Corporation Stock News

COVINGTON, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq/GSM:POOL) announced today that its Board of Directors declared a quarterly cash dividend of $1.20 per share. The dividend will be payable on March 26, 2025, to holders of record on March 12, 2025.

This Berkshire/Buffett holdings-list from Kiplinger first appeared 12/31/24 on BKH's SEC Form13F. Kiplinger, YCharts, and Dogs-of-The-Dow all track this BRK batch. Here is your update from 2/19/25 YCharts data.

Pool Corporation (NASDAQ:POOL ) Q4 2024 Results Conference Call February 20, 2025 11:00 AM ET Company Participants Melanie Hart - Vice President, Chief Financial Officer, and Treasurer Peter Arvan - President and Chief Executive Officer Conference Call Participants Susan Maklari - Goldman Sachs Ryan Merkel - William Blair Scott Schneeberger - Oppenheimer David Manthey - Baird Andrew Carter - St...

Highlights include: Annual net sales of $5.3 billion , anchored by a consistent stream of recurring maintenance product sales Operating income of $617.2 million , maintaining a solid operating margin of 11.6% Net cash provided by operations of $659.2 million , or 152% of net income 2024 diluted EPS of $11.30 , or $11.07 without tax benefits 2025 diluted EPS guidance range of $11.08 - $11.58 , i...

Berkshire Hathaway initiated one position last quarter and pared bets on the financial sector, among other moves.

Berkshire Hathaway revealed that it had snapped up more than 5.6 million shares of Constellation Brands, known for beers like Corona and Modelo.

COVINGTON, La., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq: POOL) announced today that the Company will release its full year and fourth quarter 2024 earnings results before the market opens on February 20, 2025, and will hold a conference call to discuss the results at 10:00 a.m. Central Time (11:00 a.m. Eastern Time) that same day. The earnings release as well as a live webcas...

Texas Pacific Land and Taiwan Semiconductor Manufacturing were top contributors for both the quarter and the year, showcasing strong earnings growth and strategic market positioning. Despite Texas Pacific Land's strong performance, we sold our positions due to overvaluation driven by index additions, with plans to re-invest post-market correction. Edwards Lifesciences' EARLY TAVR trial results ...